News & Press: Patient Safety

FDA Adds New Safety Warnings to Prescription Opioid Medications

Tuesday, March 22, 2016  
Share |

The U.S. Food and Drug Administration (FDA) is warning about several safety issues with the entire class of opioid pain medicines. See the FDA Drug Safety Communication for a complete listing. These safety risks are potentially harmful interactions with numerous other medications, problems with the adrenal glands, and decreased sex hormone levels. FDA is requiring changes to the labels of all opioid drugs to warn about these risks.

See the FDA Drug Safety Communication for additional information, including a listing of opioids, serotonergic medicines, and a data summary.

Read the MedWatch safety alert at:

Contact Us

120 E. Ogden Ave. Ste. 202
Hinsdale, Illinois 60521
P: 630.203.2252
Toll Free: 888.255.0005

© Copyright 2016 Spine Intervention Society Privacy Policy  ::  Legal